Overview

• Billy Evans, Elizabeth Holmes’s partner, has raised millions toward a $50 million goal for his blood-testing startup, Haemanthus.
• Haemanthus markets itself as “the future of diagnostics” and plans to use light-detection technology for testing bodily fluids, according to a recently granted patent.
• The company’s prototype bears a striking resemblance to Theranos’s Edison device, raising concerns about parallels to Holmes’s fraudulent venture.
• Evans reportedly plans to begin diagnostics testing on pets before expanding to humans, though the regulatory oversight remains unclear.
• Sources allege that Holmes, serving an 11-year sentence for fraud, has been advising Evans on the startup from her prison in Bryan, Texas.